Labcorp Holdings Inc.
LHDCF · Perpetuity growth · 5y leads for a mature, steady company — positive operating income and three years of positive free cash flow. From a five-year discounted cash flow.
Price and model value
What the marks mean
Valuation models
DCF · Perpetuity growth · 5y leads for a mature, steady company — positive operating income and three years of positive free cash flow. How we value a stock walks through every input.
Dividends
- Dividends / free cash flow, FY2025
- 20.0%
- Raised
- —
- Growth, 3 yrs
- 3.8% a year
- Last change
- +16.4% · Aug 2023
Research on LH
How it is valued
Key figures
Superinvestors
Analyst actions
Recent
Comparable companies
2 more companies list LH as a comparable
The weekly
One email a week across every stock we cover: 13F filings, insider trades, earnings and new research. It covers the whole market, not just LH. No account.
About Labcorp
Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.
- CEO
- Adam H. Schechter
- Headquarters
- Burlington, NC
- Employees
- 71,000
- IPO
- 1990-03-29
Model estimates for research reference only, not investment advice. Every model rests on assumptions that may not match what happens; the formulas are in how we value a stock.